News and Press Releases

Cytiva expands Fast Trak process development and validation services facility in India

Around 30,000 ft2 center will help biopharma shorten development timelines, reduce risk, and scale with confidence Supports multiple modalities including mAbs, pDNA/mRNA, recombinant proteins, and viral vectors. 25 February 2026 --...

Category: BioManufacturing, Drug Discovery, Manufacturing and Packing, Other, Pharmaceutical
Posted: February 25, 2026

Global Life Sciences Solutions USA LLC 1209 Orange Street Wilmington DE 19801 United States

BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure

Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds Aurase shows dual action on chronic wound debridement and healing SolasCure preparing fund raising for...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 25, 2026

Darmstädter Straße 34 – 36 64673 Zwingenberg Deutschland

Etihad Cargo Launches Etihad Cargo Excellence Hub

Abu Dhabi, U.A.E – 25 February 2026: Etihad Cargo, the cargo and logistics arm of Etihad Airways, announces the launch of the air cargo industry's first logistics training academy by an airline. The...

Category:
Posted: February 25, 2026

SolasCure completes phase II clinical trial, demonstrating accelerated healing with Aurase Wound Gel

Aurase Wound Gel shows 22x faster debridement and 7x faster healing compared to standard of care in sloughy venous leg ulcers, supporting advancement to the next phase of development Data...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 24, 2026

wellington house East Rd, Petersfield, Cambridge CB1 1BH

PMGroup Worldwide Ltd, a wholly owned subsidiary of Datateam Business Media Ltd, adds Laboratory News to publications portfolio

24 February 2026 -- London, UK -- PMGroup Worldwide Ltd are pleased to announce the acquisition of Laboratory News magazine and website, together with Laboratory Talk website, from Synthesis Media. Laboratory News has for...

Category: BioManufacturing, Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 24, 2026

Mansard House, Church Road, Little Bookham, Leatherhead, Surrey, KT23 3JG

Cold Chain Technologies opens major Mumbai facility

Cold Chain Technologies (CCT) has officially opened a new 42,000-square-foot, state-of-the-art facility in Taloja, Navi Mumbai, further expanding its presence in India. The site, which integrates CCTs global portfolio with...

Category:
Posted: February 24, 2026

29 Everett Street, Holliston, MA 01746

Avid Bioservices Announces Grand Opening of New Early Phase Center of Excellence in Costa Mesa, California

24 February 2026 -- California, US -- Avid Bioservices, Inc., a dedicated biologics CDMO, today announced the grand opening of its new Early Phase Center of Excellence, a state of...

Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: February 24, 2026

14191 Myford Road Tustin, California 92780

Etihad Cargo Delivers Strong 2025 Performance with 9% Volume Growth and 8% Revenue Increase

Abu Dhabi, U.A.E. - 24 February 2026: Etihad Cargo, the logistics arm of Etihad Airways, delivered strong performance in 2025, increasing revenue by 8% year-on-year while transporting 703,000 leg tonnes,...

Category:
Posted: February 24, 2026

NICE Recommends TEPKINLY▼ (epcoritamab), a Subcutaneous Bispecific Antibody for Adults With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) After Two or More Lines of Systemic Therapy

Epcoritamab can now be accessed as an option to treat relapsed or refractory follicular lymphoma in adults after 2 or more lines of systemic treatment, only if epcoritamab is stopped...

Category: Drug Discovery, Other, Pharmaceutical
Posted: February 23, 2026

AbbVie House Vanwall Business Park Vanwall Road Maidenhead Berkshire SL6 4UB

Primera Selects Cenevo’s Labguru to Transition from Paper to Digitalised Workflow

London & Princeton, New Jersey – February 18, 2026 – Primera Analytical Solutions (Primera), an FDA-compliant analytical Contract Research Organization (CRO), has selected Cenevo’s Labguru electronic lab notebook (ELN) and inventory management platform to streamline its...

Category:
Posted: February 19, 2026

18/19 Bickels Yard 151-153 Bermondsey Street London SE1 3HA

Cold Chain Technologies boosts its commitment to Cell & Gene Therapies by partnering with Gobi Technologies

Cold Chain Technologies (CCT) has announced a strategic partnership with Gobi Technologies to give customers access to a greater range of temperature-controlled containers for Cell and Gene Therapies. The deal...

Category:
Posted: February 19, 2026

29 Everett Street, Holliston, MA 01746

Proveris Laboratories Launches Redesigned Website Focused on Analytical Clarity in OINDP Development

Hudson, MA, February 18, 2026 — Proveris Laboratories announced the launch of a redesigned website centered on its analytical and regulatory expertise in orally inhaled and nasal drug product (OINDP)...

Category:
Posted: February 19, 2026

2 Cabot Road, Hudson, MA

Emmes Coordinates Groundbreaking Stem-Cell Ophthalmology Trial

18 February 2026 -- Maryland, US -- Emmes, a full-service, global Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation – in collaboration with the UC Davis Eye...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 18, 2026

401 North Washington Street Suite 700 Rockville, MD 20850

Oncoinvent to Present Positive 24-month Follow-up Data from Phase 1 Ovarian Cancer Study of Radspherin at ESGO 2026

9 of 10 patients at the highest dose remained free from peritoneal recurrence at 24 months at the recommended dose 17 February 2026 -- Oslo, Norway -- Oncoinvent, a biotech...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 17, 2026

Gullhaugveien 7 0484 Oslo Norway

FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference

Presentation will highlight lead clinical candidate FMP374, a novel dual-acting NMDAR modulator advancing toward IND-enabling studies for TRD 17 February 2026 -- Heidelberg, Germany -- FundaMental Pharma GmbH, a preclinical-stage...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: February 17, 2026

Nikola-Tesla-Straße 1 D-69124 Heidelberg / Germany